Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddys Lab reports Profit after tax of Rs 3115.00 Mln, in the March 2021 quarter
Date: 14-05-2021
The March 2021 quarter revenue stood at Rs. 33507.00 millions, up 17.50% as compared to Rs. 28517.00 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 3115.00 millions from Rs. 5028.00 millions, a decline of -38.05% on QoQ basis.The company reported a good operating profit of 6845.00 millions compared to 6482.00 millions of corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202103 | 202003 | % Var | 202103 | 202003 | % Var | 202103 | 202003 | % Var | |
| Sales | 33507.00 | 28517.00 | 17.50 | 133491.00 | 118504.00 | 12.65 | 133491.00 | 118504.00 | 12.65 |
| Other Income | 816.00 | 1274.00 | -35.95 | 8011.00 | 7432.00 | 7.79 | 8011.00 | 7432.00 | 7.79 |
| PBIDT | 6845.00 | 6482.00 | 5.60 | 39529.00 | 36128.00 | 9.41 | 39529.00 | 36128.00 | 9.41 |
| Interest | 169.00 | 118.00 | 43.22 | 467.00 | 478.00 | -2.30 | 467.00 | 478.00 | -2.30 |
| PBDT | 6676.00 | 6364.00 | 4.90 | 39062.00 | 35650.00 | 9.57 | 39062.00 | 35650.00 | 9.57 |
| Depreciation | 2107.00 | 1923.00 | 9.57 | 8500.00 | 7892.00 | 7.70 | 8500.00 | 7892.00 | 7.70 |
| PBT | 4569.00 | 4441.00 | 2.88 | 30562.00 | 27758.00 | 10.10 | 30562.00 | 27758.00 | 10.10 |
| TAX | 1454.00 | -587.00 | -347.70 | 8698.00 | -1619.00 | -637.25 | 8698.00 | -1619.00 | -637.25 |
| Deferred Tax | 666.00 | -1277.00 | -152.15 | 3297.00 | -6458.00 | -151.05 | 3297.00 | -6458.00 | -151.05 |
| PAT | 3115.00 | 5028.00 | -38.05 | 21864.00 | 29377.00 | -25.57 | 21864.00 | 29377.00 | -25.57 |
| Equity | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 | 832.00 | 831.00 | 0.12 |
| PBIDTM(%) | 20.43 | 22.73 | -10.13 | 29.61 | 30.49 | -2.87 | 29.61 | 30.49 | -2.87 |